August 31 – September 1

Display of Antibodies

Antibodies for Cancer Therapy

Improving Immunotherapy Efficacy and Safety

Difficult-to-Express Proteins

Characterization for Novel Biotherapeutics

Immunogenicity Case Studies and Clinical Management

Emerging Indications for Therapeutic Antibodies

September 1

Overview of Biologic COVID-19 Interventions

September 2-3

Engineering Antibodies

Advancing Bispecific Antibodies and Combination Therapy to the Clinic

CAR Ts, TCRs and TILs

Biophysical Methods

Optimizing Protein Expression

Immunogenicity Assessment and Regulatory Approval of Biologics

Engineering Antibody-Drug Conjugates

Gene Therapy

September 3-4

Engineering Bispecific Antibodies

Clinical Progress of Antibody-Drug Conjugates

Agonist Immunotherapy Targets

Cell and Gene Therapy Analytics

Protein Expression System Engineering

Optimizing Bioassays for Biologics